Home » Topics » Regulatory » Patents

Patents
RSS

New use claimed for olanzapine

Nov. 26, 1996

Melatonin receptor ligands described by ADIR

Nov. 26, 1996

New retinoid-like compounds from BMS

Nov. 26, 1996

New NMDA antagonists described by Zeneca

Nov. 26, 1996

Asta Medica reports new PDE IV and PDE V inhibitors

Nov. 26, 1996

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

New antihypertensive agent from Calpis Food Industry

Nov. 26, 1996

Sandoz claims MAbs against Lewis group antigens for therapeutic use

Nov. 25, 1996

More antiobesity proteins reported by Lilly

Nov. 25, 1996

Maxi-K channel modulators from Bristol-Myers Squibb

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.